company background image
MDR

MedAdvisor ASX:MDR Stock Report

Last Price

AU$0.17

Market Cap

AU$92.5m

7D

-10.5%

1Y

-55.8%

Updated

25 Nov, 2022

Data

Company Financials +
MDR fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

MDR Stock Overview

MedAdvisor Limited, together with its subsidiaries, develops and delivers software in Australia, the United States, the United Kingdom, and Asia.

MedAdvisor Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MedAdvisor
Historical stock prices
Current Share PriceAU$0.17
52 Week HighAU$0.40
52 Week LowAU$0.13
Beta0.53
1 Month Change-5.56%
3 Month Change21.43%
1 Year Change-55.84%
3 Year Change-45.16%
5 Year Change-48.33%
Change since IPO-53.30%

Recent News & Updates

Recent updates

MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

Jun 29
MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Nov 09
Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Is MedAdvisor (ASX:MDR) A Risky Investment?

Oct 11
Is MedAdvisor (ASX:MDR) A Risky Investment?

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Mar 08
Is MedAdvisor (ASX:MDR) Using Too Much Debt?

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

Feb 10
MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

Jan 18
What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

Dec 22
The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Dec 18
What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Nov 22
Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Shareholder Returns

MDRAU Healthcare ServicesAU Market
7D-10.5%0.4%1.2%
1Y-55.8%-16.1%-2.9%

Return vs Industry: MDR underperformed the Australian Healthcare Services industry which returned -16.4% over the past year.

Return vs Market: MDR underperformed the Australian Market which returned -3.1% over the past year.

Price Volatility

Is MDR's price volatile compared to industry and market?
MDR volatility
MDR Average Weekly Movement9.7%
Healthcare Services Industry Average Movement10.3%
Market Average Movement9.0%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market4.2%

Stable Share Price: MDR is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: MDR's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/aRick Ratliffhttps://www.mymedadvisor.com

MedAdvisor Limited, together with its subsidiaries, develops and delivers software in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs; THRiV, an intelligent digital adherence solution; and GuildCare, a cloud-based platform that offers healthcare solutions and medicines information for consumers, health professionals, and other partners. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.

MedAdvisor Limited Fundamentals Summary

How do MedAdvisor's earnings and revenue compare to its market cap?
MDR fundamental statistics
Market CapAU$92.45m
Earnings (TTM)-AU$17.35m
Revenue (TTM)AU$67.75m

1.4x

P/S Ratio

-5.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MDR income statement (TTM)
RevenueAU$67.75m
Cost of RevenueAU$70.84m
Gross Profit-AU$3.09m
Other ExpensesAU$14.25m
Earnings-AU$17.35m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.032
Gross Margin-4.57%
Net Profit Margin-25.60%
Debt/Equity Ratio32.2%

How did MDR perform over the long term?

See historical performance and comparison